Isovalerylcarnitine is a specific activator of the high calcium requiring calpain forms (Q68722445)
scientific article published on 01 February 1990
Language:
Current Data About Isovalerylcarnitine is a specific activator of the high calcium requiring calpain forms
(P31) (Q13442814)
(P248)
(P698) 2310400
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2310400%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, September 26, 2019

(P304) 373-380
(P248)
(P698) 2310400
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2310400%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, September 26, 2019

(P407) (Q1860)

(P433) 1
(P248)
(P698) 2310400
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2310400%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, September 26, 2019

(P478) 167
(P248)
(P698) 2310400
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2310400%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, September 26, 2019

(P577) Thursday, February 1, 1990
(P248)
(P698) 2310400
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2310400%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, September 26, 2019

(P1433) (Q864228)
(P248)
(P698) 2310400
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2310400%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, September 26, 2019

(P1476) "Isovalerylcarnitine is a specific activator of the high calcium requiring calpain forms" (language: en)
(P248)
(P698) 2310400
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2310400%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, September 26, 2019

(P2093) S Pontremoli
(P1545) 1
(P248)
(P698) 2310400
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2310400%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, September 26, 2019

E Melloni
(P1545) 2
(P248)
(P698) 2310400
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2310400%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, September 26, 2019

P L Viotti
(P1545) 3
(P248)
(P698) 2310400
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2310400%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, September 26, 2019

M Michetti
(P1545) 4
(P248)
(P698) 2310400
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2310400%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, September 26, 2019

F Di Lisa
(P1545) 5
(P248)
(P698) 2310400
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2310400%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, September 26, 2019

N Siliprandi
(P1545) 6
(P248)
(P698) 2310400
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2310400%20AND%20SRC:MED&resulttype=core&format=json
(P813) Thursday, September 26, 2019

other details
description scientific article published on 01 February 1990

External Links
(P356) 10.1016/0006-291X(90)91775-N
(P698) 2310400